Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Tidewater Native and Rehabilitation Specialist Gerreyl Fleming Opens Caring Transitions of South Hampton Roads


Gerreyl Fleming

Whether that change is planned or unexpected, when you work with Caring Transitions, we can partner with you to help you meet your goals without the physical or emotional strain of doing it yourself. – Gerreyl Fleming

Tidewater native Gerreyl Fleming is pleased to announce the launch of her new senior-focused relocation and estate clearing company, Caring Transitions of South Hampton Roads.

Caring Transitions’ specially-trained professionals handle decluttering, organizing, packing, moving, resettling, in-home estate sales and online auctions, home clean-outs, estate clearing and preparing homes for market. Caring Transitions of South Hampton Roads works with clients in Western Branch, Harbor View, Nansemond River, Churchland, Suffolk, Chesapeake, Portsmouth and the surrounding areas, including Virginia Beach.

Caring Transitions’ services are perfect for managing the many aspects of a senior move, including assisting with the process of downsizing to provide a safer living situation, as well as for busy families and people clearing out the home of a loved one who has moved into assisted care or passed away. All of Caring Transitions’ services are customizable, so clients choose the solution that best fits their needs.

“As a rehabilitation specialist, I worked with quite a few seniors who faced changing needs, whether because of their health or their living situation, and sometimes those needs changed very quickly. So what do you do when you have to transition that fast? That’s what led me to Caring Transitions,” Fleming said. “Whether that change is planned or unexpected, when you work with Caring Transitions, we can partner with you to help you meet your goals without the physical or emotional strain of doing it yourself.”

After graduating from Washington High School she earned a BS in kinesiology from Wheaton College in Illinois. She spent a couple of years working for the local YMCA, which started a life-long appreciation for that organization. After serving adolescents and seniors with disabilities with Barry Robinson Center and Eggleston services for a short time, she attended James Madison University to become an Occupational Therapist. Now, as the owner of Caring Transitions, Fleming is also a Certified Relocation and Transition Specialist.

“Caring Transitions is unique because of our specialized training, focus on seniors and customizable services. We want to speed up your transition, relieve the stress and protect your family relations by being a third party partner who is there to serve your family by providing solutions,” Fleming said.

Caring Transitions of South Hampton Roads, which is part of the national Caring Transitions franchise, is bonded and insured and all employees are background checked. For additional information, call 757-574-2450, email GFleming@CaringTransitions.com or visit http://www.CaringTransitionsHamptonRoads.com.

Share article on social media or email:

FDAnews Announces 17th Annual Medical Device Quality vCongress Oct. 7-8, 2020


WCG CenterWatch

WCG CenterWatch

17th Annual Medical Device Quality vCongress

Thursday, Oct. 8, 2020 • 1:00 p.m.-4:15 p.m. EDT

https://www.fdanews.com/mdqc

Attend the premier event for device quality and compliance professionals: the 17th Annual Medical Device Quality vCongress. This virtual program is filled with up-to-the-minute topics needed to manage quality programs in the U.S. and EU.

A special focus on the new EU Medical Device Regulation (EU-MDR) will ensure one’s compliance in Europe. With the Medical Device Quality vCongress taking place a few months before the May 2021 EU-MDR deadline, attendees can easily fine-tune plans — and strengthen product positions — in advance of these sweeping changes.

The Medical Device Quality vCongress’s virtual sessions will cover critical U.S. and international topics, including:


  • Impact of new economic operators in the EU-MDR and EU In Vitro Diagnostics Regulation (EU-IVDR) — the key to business success in the EU
  • Implementation of the clinical evaluation (EU-MDR) or performance evaluation process (EU-IVDR) — what one needs to know to obtain a CE Mark
  • Quality management system (QMS) under EU-MDR and EU-IVDR — create a foolproof QMS
  • Complaint reporting — save time and money by avoiding resubmission requests with U.S. medical device reporting (MDR) and EU-MDR’s/IVDR’s new manufacturer’s incident report (MIR)
  • Corrective actions — U.S. and EU perspectives, including EU-MDR/IVDR field safety corrective actions (FSCAs), field safety notice (FSN) and other reports one must file to ensure compliance
  • Risk management systems (RMS) under ISO 14971:2019, including European norms — practical ways to implement both in one unified system
  • Postmarket surveillance (PMS) in EU-MDR/IVDR — take a more proactive approach and implement a compliant system

Mark your calendar for Oct. 7-8 to interact virtually with FDA officials, consultants, lawyers, experts and colleagues — before EU-MDR’s deadline. This virtual event provides all the benefits of a live MDQC but allows you to attend remotely. No travel, no hassle!

This is 2020’s most important event for devicemakers: the 17th Annual Medical Device Quality vCongress.

Multi-attendee discounts available!

Significant tuition discounts are available for teams of two or more from the same company.

Virtual Conference Details:

17th Annual Medical Device Quality vCongress

Thursday, Oct. 8, 2020 • 1:00 p.m.-4:15 p.m. EDT

https://www.fdanews.com/mdqc

Tuition:

Regular Pricing: $697

Easy Ways to Register:

Online: https://www.fdanews.com/mdqc

By phone: 888.838.5578 or 703.538.7600

About FDAnews:

FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews’ print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA’s complex and ever-changing regulations

Share article on social media or email:

American College of Lifestyle Medicine Announces New CME/CE Course on Physician and Health Professional Physical and Emotional Well-Being to Prevent Burnout


News Image

“Our course promotes thriving and flourishing in the face of adversity and preventing symptoms of burnout before they occur.”

The American College of Lifestyle Medicine (ACLM) today announced the availability of its new five-hour CME- and CE-accredited five-hour course, “Physician and Health Professional Well-Being,” designed to support physicians and other health professionals in achieving and sustaining a total healthy lifestyle. In addition to encouraging eating a predominantly whole food plant-based diet and being physically active, the course includes mindfulness and positive psychology activities. The self-care approaches as discussed in the course, in combination with system changes that support a culture of well-being in the health care workplace, can help individuals stay physically and emotionally healthy and prevent burnout.

The new course is designed for physicians, physician assistants, nurse practitioners, registered nurses, pharmacists, registered dietitians, physical therapists, occupational therapists, psychologists, social workers and others.

This course, spearheaded by faculty lead Liana Lianov, MD, MPH, FACLM, FACPM, DipABLM, offers exercises to harness personal strengths and leadership skills for improving workplace culture and systems and to engage in effective, positive health care team and patient interactions. Learners will also conduct a well-being assessment and develop a personal action plan.

Formerly ACLM’s president, Lianov is chair of the organization’s Happiness Science and Positive Health Committee. She also is president of the Positive Health and Wellness Division of the International Positive Psychology Association and vice chair of the American Board of Lifestyle Medicine. She led ACLM’s inaugural Summit on Happiness Science in Health Care held in 2018 in partnership with Dell Medical School at The University of Texas at Austin and was editor of the recently released groundbreaking book, Roots of Positive Change: Optimizing Health Care with Positive Psychology.

“To clarify, our new course is not for individuals who are already experiencing symptoms of burnout, such as emotional exhaustion, depersonalization or a significant decrease in sense of accomplishment,” said ACLM President Dexter Shurney, MD, MBA, MPH, FACLM, DipABLM. “Rather, our course promotes thriving and flourishing in the face of adversity and preventing symptoms of burnout before they occur. This course encourages and provides ideas for modeling and leading a culture of well-being in the workplace.”

Researchers at George Mason University found that 31.6% of primary care physicians were reporting burnout, predicted to increase as a result of the 2020 Covid-19 pandemic, with burnout also impacting all members of the clinical practice team.

“One of the reasons membership in the American College of Lifestyle Medicine has grown more than 700 percent in the past five years alone is that providers who practice Lifestyle Medicine are able to specialize in health restoration, as opposed to disease management as the outcome goal,” said ACLM Executive Director Susan Benigas. “Restoring health in their patients is what reignites their passion for why they went into the field of medicine—to become true healers. Lifestyle Medicine is a powerful antidote to prevent provider burnout, and ACLM’s new online provider well-being course is, I guess you could say, just what the doctor ordered!”

To learn more, see https://bit.ly/3jgANPb

ABOUT ACLM: The American College of Lifestyle Medicine (ACLM) is the medical professional society for those dedicated to the advancement and clinical practice of Lifestyle Medicine as the foundation of a transformed and sustainable health care system. Lifestyle Medicine is the use of a whole food, plant-predominant dietary lifestyle, regular physical activity, restorative sleep, stress management, avoidance of risky substances and positive social connection as a primary therapeutic modality for treatment and reversal of chronic disease. Learn more at lifestylemedicine.org.

Share article on social media or email:

R-Zero Democratizes Access to Hospital-Grade UV-C Technology, Helping America Get Back to Business


R-Zero Systems Logo

R-Zero Systems Logo

R-Zero, a biosafety company that aims to reduce the spread of infectious disease, today announced the availability of its hospital-grade UV-C disinfection device, Arc, for mainstream businesses. This marks the first time that germicidal UV-C disinfection technology is commercially accessible through affordable pricing and operational ease. To fast-track distribution, R-Zero closed a $15M Series A round of financing led by DBL Partners with participation from Bedrock Capital. As part, Ira Ehrenpreis, Managing Partner at DBL Partners, has joined R-Zero’s Board of Directors.

Hospital-grade UV-C technology isn’t a new invention. For over a century, it has been used to fend off infectious diseases using energetic waves of ultraviolet light known as germicidal UV that wipe out viruses, bacteria and other microorganisms. Decades of research proves that germicidal UV can effectively inactivate surface and airborne microbes that transmit century old diseases such as the measles, tuberculosis, and coronavirus. But until now, UV-C disinfection technology has been limited to hospitals, where costs can range between $60,000 and $125,000 per unit, and are too cumbersome to integrate in a way that’s safe for businesses and consumers.

“In a time when an invisible microorganism is causing unprecedented human suffering and economic destruction on a truly global scale, businesses everywhere need solutions that enable them to reopen doors and keep them open safely,” said Grant Morgan, CEO and Co-founder of R-Zero. “But in order for businesses to successfully reopen, people need to feel safe in common spaces. We see a massive opportunity to create safer environments for organizations of all shapes and sizes using the same proven disinfection technologies that hospitals have relied on for decades. We’re incredibly grateful for our investors and customers who share our view that democratizing access to the most effective hospital-grade disinfection technologies is the key to restoring consumer trust and stopping the spread of infectious disease, now and forever.”

“In today’s world, nothing is more important than the health and safety of our families, fellow employees and frontline workers, but unfortunately the cost of effective disinfection protocols has been prohibitively expensive,” said Ira Ehrenpreis, Managing Partner at DBL Partners and R-Zero board member. “Through innovation and cost reduction, R-Zero democratizes access to safety for businesses and communities alike. In much the same way as companies in other critical industries have benefited in recent years from the commitment of Impact Investing and experienced exponential growth by unlocking new technologies and attracting a new breed of entrepreneurial talent, R-Zero is similarly poised to benefit from impact investment dollars to modernize the disinfection space with its breakthrough technology aimed at addressing the critical societal issues around trust, appropriate health protocols, and the need for safer spaces.”

“Germicidal UV is highly effective at decontaminating surfaces and air, which are the two virus transmission routes we are most concerned with,” said Dr. Richard Wade, Chief Scientist at R-Zero. Dr. Richard Wade has spent the past 43 years in microbiological and chemical contamination, toxicology, corporate risk management, and environmental risk management roles for Princess Cruise Lines, Norweigan Cruise Lines as well as multiple city and state governmental bodies including his previous role as deputy chief for Cal/OSHA. “UV-C is also a non-toxic disinfection solution, disinfecting both surfaces and air without the use of chemicals – which is critical in public spaces. And while the science is sound, every element of R-Zero’s touchless UV-C device has been designed to take safety into consideration.”

R-Zero was founded in the early stages of the pandemic by co-founders Ben Boyer, Grant Morgan and Eli Harris — after recognizing a unique opportunity to modernize the $20B+ infection prevention industry and help businesses increase employee and customer safety. R-Zero’s flagship germicidal UV-C device, Arc, successfully offers the same or better safety and efficacy as the systems used in hospitals — at a fraction of the price (via hardware-as-a-service lease). And while Arc’s high efficacy makes it an ideal option for clinical settings, it was designed to also work seamlessly in the many dynamic environments found outside of a hospital – including schools, restaurants, hotels, offices (and CRE), manufacturing environments, professional athletic facilities and more.

Now, just five months after inception, R-Zero’s UV-C system is actively rolling out across a range of industries and environments that recognize R-Zero as a safe and effective way to resume operations and restore trust.

As schools face entirely new challenges in reopening, R-Zero has partnered with several state education associations across the U.S. to help support and inform administrations how to best set up new health and safety protocols and minimize environmental risk so students, teachers and faculty can return to campuses safely.

“I am extremely optimistic about germicidal UV-C as a whole-room disinfection solution for a school environment,” sand Dr. Brent Clark, Executive Director of the Illinois Association of School Administrators and former Superintendent. “Incorporating hospital-grade technology into regular cleaning and disinfecting protocols will provide an added layer of protection for students and teachers, without the use of chemicals, which is critical.”

While R-Zero seeks to give back trust and safety to businesses and consumers in the COVID-19 era, this pandemic will ultimately have a larger impact on every aspect of modern culture and how the world looks at infectious disease. From this point forward, businesses around the globe will be putting infection prevention and environmental safety at the forefront of their day-to-day operations, potentially making technologies like UV-C a standard protocol necessary to stop the spread of new infectious diseases, in addition to the seasonal flu, norovirus, E.coli, and the common cold – all of which impact tens of millions of Americans every year.

About R-Zero

R-Zero is the first biosafety company dedicated to making the spaces we all live, learn, work, and play safer and clinically clean. Founded to help businesses protect what matters most, R-Zero’s suite of thoughtfully-designed, hospital-grade technologies and science-backed protocols reduces the transmission of pathogens and the diseases they cause – from the coronavirus to the common cold. For more information, visit http://www.rzero.com.

About Arc

R-Zero’s flagship product, Arc, is a touchless, hospital-grade germicidal UV-C device, designed for the dynamic environments of all organizations. BLE, LTE-M and GPS connectivity shares usage data in real time, providing organizations with an auditable trail of all disinfection activities. Results from recent (CDC and EPA recognized) independent lab tests prove Arc’s hospital-grade efficacy—successfully destroying over 99.99% of pathogens (including human coronavirus and norovirus) in a 1,000 sq ft space, in just 7 minutes. Design partners include Bould Design and BC Mechanical Design. For more information, visit http://www.rzero.com/arc-uvc/.

Target ALS and Spartan Launch “The Toughest Challenge For The Hardest Fight”


Target ALS and Spartan Launch Campaign to Raise Funds for ALS Research

“This is exactly the type of challenge Spartans are looking for… I’m really excited we can use our community’s spirit to join the fight against ALS,” said Joe DeSena, Spartan Founder, CEO & “Toughest Challenge” Campaign Co-Chair.

Despite more than 150 years of research, there remains no truly effective treatment for ALS, at least not yet. As a leading nonprofit organization in the far-reaching ALS community, Target ALS continues this fight day after day. We do so alongside our many research partners and will continue until effective treatments are discovered, which will be a tremendous leap forward in our mission: to realize a world where no one dies of ALS. Understanding that this is indeed a battle — one we can win, if we remain relentless in the pursuit — Target ALS has joined forces with Spartan to launch “The Toughest Challenge For The Hardest Fight.”

This new multiyear charitable initiative challenges people to dig deep and find the grit needed to take on a virtual Spartan race from home. But “The Toughest Challenge” is not just about a physical race; it is about all of us coming together as a force against the disease. Supporters can also opt to fundraise only or donate to a team comprised of participants who will do their races individually between November 6 and 8, 2020.

“With so much attention on ALS online and in the news, I would have thought there’s already treatments that work to target the disease,” said Spartan founder, CEO and co-chair for “The Toughest Challenge,” Joe DeSena. “This is exactly the type of challenge Spartans are looking for, with so many of them active in a range of worthy causes. Defeat is out of the question, and I’m really excited we can use our community’s spirit to join the fight against ALS.”

Target ALS founder and former deputy mayor of New York City, Dan Doctoroff, and founder of the UMass ALS Cellucci Fund and former first lady of Massachusetts, Jan Cellucci, will also serve as campaign co-chairs in “The Toughest Challenge For The Hardest Fight.”

“COVID-19 has certainly affected the ability for many organizations to advance research. But it hasn’t slowed the progression of the disease. So, our team at Target ALS adopted the motto, ‘The Work Continues,’ reflecting our continued momentum in funding projects and critically needed research tools,” said Chief Development Officer Jesse Bailey. “This program with Spartan is a representation of that tenacity, and with a fun, engaging new platform, our community will join us in raising funds so that we can continue our work without delay.”

One hundred percent of donations raised through “The Toughest Challenge For The Hardest Fight” will go to funding promising drug discovery and development programs, as well as critically needed research tools for scientists to advance their research. These tools are a part of a growing suite of scientific resources already established by Target ALS and used extensively by the ALS research community without restrictions.

Dan Doctoroff founded Target ALS in 2013 after losing both his father and uncle to the disease. Knowing that something new had to be done to combat ALS, Doctoroff worked with many scientists, pharmaceutical/biotech executives, advocates and other thought leaders to identify what was needed to move research closer to clinical trials. From this, the Target ALS Innovation Ecosystem was born, which has since funded more than 175 research collaborations between scientists at academic institutions and the pharmaceutical/biotech industry.

To date, five of these programs have resulted in clinical trials.

“This is an incredible opportunity to align with a world-class brand like Spartan,” said Director of Communications Steve Schonberg. “At our core, Target ALS and Spartan live the same values: we see obstacles as opportunities to inspire communities and change lives. It’s about every individual’s contribution to the world and being part of a team who helps each other realize their full potential.”

Spartan, together with GoFundraise, has built an easy-to-use peer-to-peer platform where “The Toughest Challenge” participants can sign up to fundraise, with tools included to promote their participation on their personal, professional, and social media networks. The platform is being provided as part of Spartan’s “For a Cause” charitable initiative, which gives nonprofits an opportunity to raise funds, reflecting Spartan’s spirit of community and support.

To learn more and sign up to join Target ALS and Spartan in “The Toughest Challenge For The Hardest Fight,” visit http://www.toughestchallenge.com.

About the Disease

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a deadly neurodegenerative disease that causes progressive paralysis due to the degeneration of motor neurons, which are nerves that pass signals from the brain and spinal cord to the muscles used for functions like walking, lifting, swallowing and breathing. Patients typically survive three to five years after diagnosis.

About Target ALS

Founded in 2013 by former deputy mayor of New York City Dan Doctoroff, with support from Bloomberg Philanthropies, Target ALS is a nonprofit organization focused on fostering collaboration to accelerate ALS drug discovery and development. Our Innovation Ecosystem — a radically different approach to medical research — overcomes barriers and brings together the right people, funding and critical resources to drive the development of breakthrough therapies for ALS.

About Spartan

With more than 250 events across more than 40 countries on six continents, Spartan is the world’s largest extreme wellness and endurance brand. Providing transformation through sport, Spartan attracts more than 1 million annual participants across all fitness levels, from beginner to elite. More than 5 million participants have finished Spartan events, creating a lifestyle that extends beyond races and includes health and wellness products, training and nutrition programs and popular media content, which has made OCR one of the fastest growing sports in the world. Spartan events feature races at various distances, including the Spartan Stadion® and Spartan Sprint®: 5k and 20 obstacles; Spartan Super®: 10k and 25 obstacles; Spartan Beast®: half marathon and 30 obstacles; and Spartan Ultra™: 50k and 60 obstacles. Visit spartan.com for more information and registration.

Share article on social media or email:

Vermont Department of Economic Development announces new hire


Brittany Nevins, Vermont Captive Insurance Economic Development Director

Brittany Nevins, Vermont Captive Insurance Economic Development Director

“Maintaining a strong marketing and business development focus on this important sector is crucial and we are glad that Brittany has joined the team to continue our success in this area.” — DED Commissioner Joan Goldstein

The Vermont Department of Economic Development (DED) is pleased to announce that Brittany Nevins has been hired as the new Captive Insurance Economic Development Director. Nevins will be responsible for the marketing and business development of Vermont’s captive insurance industry, working closely with the Department of Financial Regulation and the Vermont Captive Insurance Association to continue to strengthen the state’s reputation as the premier onshore captive insurance domicile.

“Vermont has become an international leader in the captive insurance industry and we must work to continue to grow this industry in the state,” said DED Commissioner Joan Goldstein. “Maintaining a strong marketing and business development focus on this important sector is crucial and we are glad that Brittany has joined the team to continue our success in this area.”

Brittany replaces Ian Davis, Vermont’s former Director of Financial Services. “We will hit the ground running and pick up right where we left off now that Brittany has filled the position,” noted Deputy Commissioner of Captive Insurance, Dave Provost. “We are lucky to have her join the team.”

Brittany brings a wealth of experience in the economic development and regulatory sectors. Located in Texas for the last 2 plus years, Brittany served as the Community and Economic Development Specialist for Travis County, Texas, managing its property tax rebate program for businesses that sought to develop in the Austin region. Prior to that, she was a Policy Specialist for the Texas Health and Human Services Commission, where she provided support for a variety of agency regulatory programs. Brittany has a master’s degree in Sustainable Development from the SIT Graduate Institute in Brattleboro. Having lived in Latin America, she is also fluent in Spanish.

“We are excited about Brittany’s international experience as Vermont seeks to expand further into the Latin American markets,” said Richard Smith, President of the Vermont Captive Insurance Association.

“The captive insurance industry is a model for economic development in the state, bringing in clean, high paying jobs, significant tax revenue, and supports the tourism industry all at the same time,” said Nevins. “I’m humbled and thrilled to be coming back to my home state of Vermont to promote Vermont’s best-in-class captive insurance status and help grow its presence and stature throughout the world.”

For more information on Vermont’s captive industry, visit http://www.vermontcaptive.com, call Brittany Nevins at 802-398-5192 or email Brittany.Nevins@vermont.gov.

Share article on social media or email:

Connecticut Choosing Wisely Collaborative Winds Down Operations After Six Years of Promoting Widespread Adoption of Choosing Wisely® Campaign Across Connecticut


The Connecticut Choosing Wisely Collaborative (CCWC), a diverse multi-stakeholder group committed to the widespread adoption of Choosing Wisely® in Connecticut, has accomplished its goals and has decided to wind down. The group was formed in 2014 to raise awareness in Connecticut about the Choosing Wisely® campaign and to be a catalyst to accelerate the adoption of Choosing Wisely in the State. The CCWC has worked to promote Choosing Wisely as a vehicle to support efforts across Connecticut to improve health care quality, lower health care costs and advance health equity.

Choosing Wisely is an initiative of the American Board of Internal Medicine (ABIM) Foundation (http://www.abimfoundation.org) that was launched as a campaign in 2012 working with medical specialty societies and national consumer, employer, patient, healthcare, and business organizations. The campaign’s focus is to promote conversations between clinicians and patients to help them make safe and effective care decisions. The CCWC, like many formed in states across the country, has worked in partnership with other local organizations to bring the message, the resources, and tools of the campaign to patients, consumer groups, employers, payers, providers, health systems, government officials, and policy makers.

“In the first few years of the Collaborative, members of our group made dozens of presentations to a variety of medical, employer, and community-based groups introducing them to the Choosing Wisely campaign. Over time, familiarity with the campaign has grown, in part from our efforts,” said Timothy Elwell, PhD, Qualidigm President and CEO, a founding member organization of the CCWC and one of the group’s co-chairs. “Based on multiple surveys we have conducted on relative awareness, Choosing Wisely is recognized as a program that benefits patients and health systems. Our group has focused on helping provider organizations gain access to tools and resources aimed at implementing Choosing Wisely across care settings. For example, we have partnered with Federally-Qualified Health Centers (FQHCs), hospitals, and Connecticut university students in health professional schools on a variety of projects,” said Elwell.

The Collaborative has relied on its members to volunteer their time and to make modest membership contributions to cover administrative costs including website hosting, and organizing webinars, conferences, and other activities. “One of CCWC’s key accomplishments has been its focus on how the Choosing Wisely campaign can be used as a tool to promote health equity,” said Nancy Yedlin, Vice President of the Donaghue Foundation, also a founding member of the CCWC and the first chair of its leadership Council. “Our work in Connecticut, with great partners, was supported by grants from the Connecticut Health Foundation, one of the founding Collaborative members. We’ve been recognized by the American Board of Internal Medicine Foundation (ABIMF) and others as spurring action on how the campaign can better serve and support particularly African American, black and Latinx patients, families, and communities who have been underserved by our health care system,” said Yedlin.

Over time, the 15 CCWC member organizations (past and present) which include: Access Health CT, Community Health Center Association of CT (CHCACT), Community Health Network of CT, Connecticut Business Group on Health, Connecticut Health Foundation, Donaghue Foundation, Health Disparities Institute, National Physicians Alliance-CT, Office of the Comptroller of Connecticut, Office of the Healthcare Advocate, Office of Health Strategy, Connecticut Primary Care Coalition, Qualidigm, Universal Health Care Foundation of Connecticut, and UCONN Health, have increasingly incorporated Choosing Wisely into their ongoing work. Several health care systems and patient organizations have adopted the principles of Choosing Wisely throughout Connecticut.

Recently, the organization posted a report that summarizes accomplishments over the last six years. While the Collaborative will officially disband by September 30, 2020, it will maintain a static website, which may be accessed at http://www.choosingwiselyct.org/. The accomplishments report may be found on the CCWC website.

Additionally, in accordance with its Memorandum of Understanding and Bylaws, upon the completion of this last project deliverable, the organization plans on distributing all remaining assets to a worthy organization. After much deliberation, the members have agreed to donate its remaining funds to Health Resources in Action (HRiA), a Boston-based 501(c)(3) public health institute in support of the National Association of Community Health Workers (NACHW). With the CCWC funding, the NACHW (http://www.nachw.org) will be able to implement a project to advance Choosing Wisely materials, resources and learnings in Connecticut and nationally among community health worker (CHW) professionals on the front-line supporting communities to achieve health, equity and social justice.

“The CCWC has been a great partner with the national Choosing Wisely campaign and through them we have had to opportunity to work with many individuals and organization throughout Connecticut,” said Daniel Wolfson, Executive Vice-President of the ABIM Foundation. “Our organization will continue to serve as a resource to all those in Connecticut who wish to be engaged in the campaign. We encourage people to join the Choosing Wisely learning network (http://www.choosingwisely.org/choosing-wisely-learning-network) to get access to all the resources we have available.”

Efforts to improve healthcare value and health outcomes for the citizens of Connecticut will continue through other organizations in which CCWC members remain active. Of note are the Moving to Value coalition efforts and Governor Lamont’s Cost Growth Benchmark initiative being led by the Office of Health Strategy that incorporates a focus on reducing low value care using a data-based approach.

“The Collaborative would like to thank all its past and current members and the numerous other groups and individuals who, over the past six plus years, contributed their time and effort to help make Choosing Wisely an important piece of our state’s efforts to improve health care quality, lower health care costs, and advance health equity,” said Laura Morris, Director of Consumer Engagement at the State Office of Health Strategy and current CCWC co-chair.

About the Connecticut Choosing Wisely Collaborative (CCWC):

The Connecticut Choosing Wisely Collaborative (CCWC) is a diverse multi-stakeholder group that is committed to the widespread adoption of Choosing Wisely® in Connecticut. The CCWC aims to support and connect organizations developing or already involved in Choosing Wisely in Connecticut. The Collaborative promotes the development of a Choosing Wisely learning community that local programs can join and access free resources to contribute to best practices at the local and national levels.

###

KidCheck Children’s Check-In Leads Abuse Prevention Sessions at Children’s Ministry Conference


KidCheck Child Safety

KidCheck Children’s Check-In Child Safety

Keeping children safe is our top priority. KidCheck believes every child deserves a chance to grow up in a safe environment, and every parent deserves peace-of-mind about the safety of their children.

KidCheck, providers of secure children’s check-in software, is leading multiple workshops in the “Safety in Ministry” track at the virtual KidMin Nation Mega-Con Conference. The Fuel Up Session entitled “The Why and How of Screening for Safety” takes place on October 5, 2020, and the Deep Dive workshop called “Predator Proofing You Ministry” takes place on October 6, 2020.

Mega-Con is a creative, inspirational, energetic conference designed to lead those in children’s ministry into the future. It brings children’s pastors and ministry leaders together, providing networking opportunities, inspiring speakers, a multitude of workshops, and access to many ministry tools and resources.

The workshops are led by Angela Lewton, KidCheck’s Child Protection Specialist, and are designed to provide insight on the leading concerns around child security and safety. They deliver actionable ideas and best practices for organizations caring for children to create a safe environment and minimize any possible safety and security concerns.

“Abuse prevention is a difficult, yet important topic,” said Alex Smith, KidCheck CEO. “These workshops will focus on who predators are, how they operate, prevention methods, protective measures, the steps for comprehensive screening and how to implement them properly.”

“Keeping children safe is our top priority. KidCheck believes every child deserves a chance to grow up in a safe environment, and every parent deserves peace-of-mind about the safety of their children,” continued Smith. “We are excited to speak at the Mega-Con conference again this year to share information and best practices around child safety.”

About KidCheck

KidCheck, Inc. provides secure children’s check-in software and complete check-in station systems for churches, fitness facilities, and organizations caring for children. KidCheck believes every child deserves a chance to grow in a safe environment, and every parent deserves peace-of-mind about the safety of their children. KidCheck is committed to delivering easy-to-use, innovative, and reliable check-in systems backed by world class support. To learn more or to request a demo visit http://www.kidcheck.com.

Share article on social media or email:

NeoTract Designates Dr. Sheldon Pike as UroLift® Center of Excellence


News Image

“This designation recognizes Dr. Sheldon Pike as a UroLift Center of Excellence for his commitment to providing safe and effective treatment to patients with BPH,” said Dave Amerson

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Sheldon Pike, M.D., New York Health in Lawrence, NY, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Pike has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“This designation recognizes Dr. Sheldon Pike as a UroLift Center of Excellence for his commitment to providing safe and effective treatment to patients with BPH,” said Dave Amerson, president of the Teleflex Interventional Urology business unit. “We are pleased to see the continued acceptance of the UroLift System as a standard of care treatment that may allow men to discontinue the use of BPH medications and improve their quality of life.”

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

# # #

For Teleflex Incorporated: Jake Elguicze, 610.948.2836

Treasurer and Vice President, Investor Relations

Media:

Nicole Osmer, 650.454.0504

nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction

1. Roehrborn, J Urology 2013 LIFT Study

2. McVary, J Sex Med 2016

MAC00968-01 Rev A

Share article on social media or email:

The President’s Executive Orders Promise Drug Price Reform: But Will They Deliver?


Going into the 2020 election, drug pricing remains a key topic of discussion.

While lawmakers continue to promise reform, nearly all regulatory progress stalls before it can take effect.

Going into the 2020 election, drug pricing remains a key topic of discussion, and has been so for a long time as almost half of all Americans take at least one prescription medication daily.(1) While lawmakers continue to promise reform, nearly all regulatory progress stalls before it can take effect. The key to understanding why, says Innopiphany, a California-based Life Sciences consulting firm, lies in a thorough understanding of the process by which effective action takes place and then communicating that to the American public.

Over the past four years, the Trump administration and Congress have introduced several executive orders and rules that are all intended to lower drug prices, but none have made a significant impact. These proposals target a range of factors relating to drug pricing, including rebate structures, manufacturer transparency, drug pricing inclusion for direct to consumer advertising, and drug importation laws. In July, President Trump signed four executive orders(2), which were followed by another executive order, signed in September 2020, intended to ensure that Americans pay the “most favored nation price” for pharmaceuticals sold in other countries with comparable per-capita gross domestic product.

Trump’s attack strategy on drug pricing has been waged through social media outlets such as Twitter, but pushback from drug manufacturers and others has been consistent on those same outlets as well as through more traditional routes. This pushback has been particularly marked in the case of the “most favored nation price” order, which would send waves, not ripples, throughout the pharmaceutical industry.

Although these proposed policies may help garner more votes at the election booth, there are still specific rules and regulatory processes that lawmakers must follow to enact each executive order, which can take months if not years.

There may be mechanisms through which the administration could accelerate or sidestep the standard approval process, such as issuing an interim final rule, but such a move will receive an even stronger pushback from the pharmaceutical industry.

Many key pharmaceutical industry players have already blasted the president and his policies, with some noting that the orders were conveniently released close to the next presidential election.(3) Some, such as Pfizer, have announced that they would reconsider U.S. expansions or even cut jobs if the measures detailed in the executive orders are implemented.(4)

“It takes expertise and experience to look behind the rhetoric of such regulatory action and understand the real policies and due process. At Innopiphany, we have such expertise to evaluate likely scenarios, timelines, and implications of these executive orders and other suggested drug policy changes,” said Phil Ball, Principal, Head of Policy Practice.

About Innopiphany

Innopiphany is a Life Sciences consulting firm which specializes in Market Strategy, Forecasting, Market Access, Health Economics Outcomes Research (HEOR), and Healthcare Policy. All services are supported by advanced analytics, including data mining, data blending, natural language processing, predictive analytics, and data visualizations. The company has generated $150 million in new healthcare business in 30 countries for its clients. Innopiphany has achieved 100 percent repeat business from its clients through its rapid, on-time project delivery. Its headquarters are located in Los Angeles, CA. For more information, visit innopiphany.com.

1. Hagan, Shelly. “Nearly One in Two Americans Takes Prescription Drugs: Survey.” Bloomberg.com, Bloomberg, 8 May 2019, bloomberg.com/news/articles/2019-05-08/nearly-one-in-two-americans-takes-prescription-drugs-survey.

2. U.S. Department of Health and Human Services. “Trump Administration Announces Historic Action to Lower Drug Prices for Americans.” HHS.gov, US Department of Health and Human Services, 24 July 2020, hhs.gov/about/news/2020/07/24/trump-administration-announces-historic-action-lower-drug-prices-americans.html.

3. Sagonowsky, Eric. “FiercePharmaPolitics-Trump and Big Pharma Tussle over Drug Price Proposal with 3 Months until Election.” FiercePharma, 3 Aug. 2020, fiercepharma.com/pharma/fiercepharmapolitics-trump-and-big-pharma-tussle-over-drug-price-proposal-3-months-til.

4. Blankenship, Kyle; Fierce Pharma, “Pfizer CEO: We may cut jobs, backpedal on expansions if Trump’s pricing orders take effect”; 29 July 2020’ | fiercepharma.com/pharma/pfizer-ceo-bourla-blasts-trump-s-radical-executive-orders-drug-pricing

Share article on social media or email: